Lenvatinib + pembrolizumab treats advanced endometrial cancer

(HealthDay)—For patients with advanced endometrial cancer, lenvatinib plus pembrolizumab results in significantly longer progression-free and overall survival than the physician's choice of chemotherapy, according to a ...

Oncology & Cancer

Study: New approach may boost prostate cancer immunotherapies

Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body's immune cells fight the cancer. The discovery, made in human and mouse cells and in laboratory mice, could lead ...

page 1 from 9